Stock Analysis on Net
Stock Analysis on Net

Elevance Health Inc. (NYSE:ELV)

デュポン分析: ROE、ROA、純利益率の内訳 
四半期データ

Microsoft Excel

ROE分解では、純利益を株主資本で割ったものを構成比率の積として表します。

ROEを2つのコンポーネントに分解

Elevance Health Inc.、 ROE の分解(四半期データ)

Microsoft Excel
ROE = ROA × 財務レバレッジ比率
2024/03/31 15.38% = 5.58% × 2.76
2023/12/31 15.23% = 5.50% × 2.77
2023/09/30 15.82% = 5.50% × 2.88
2023/06/30 16.78% = 5.87% × 2.86
2023/03/31 16.62% = 5.69% × 2.92
2022/12/31 16.59% = 5.86% × 2.83
2022/09/30 17.26% = 6.03% × 2.86
2022/06/30 17.04% = 6.05% × 2.82
2022/03/31 17.36% = 6.21% × 2.79
2021/12/31 16.93% = 6.26% × 2.70
2021/09/30 15.44% = 5.63% × 2.74
2021/06/30 12.10% = 4.40% × 2.75
2021/03/31 13.92% = 4.93% × 2.83
2020/12/31 13.77% = 5.28% × 2.61
2020/09/30 14.61% = 5.72% × 2.55
2020/06/30 17.17% = 6.72% × 2.55
2020/03/31 15.08% = 5.80% × 2.60
2019/12/31 15.15% = 6.21% × 2.44
2019/09/30 — = — × 2.48
2019/06/30 — = — × 2.46
2019/03/31 — = — × 2.48

レポートに基づく: 10-Q (報告日: 2024-03-31), 10-K (報告日: 2023-12-31), 10-Q (報告日: 2023-09-30), 10-Q (報告日: 2023-06-30), 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31), 10-K (報告日: 2020-12-31), 10-Q (報告日: 2020-09-30), 10-Q (報告日: 2020-06-30), 10-Q (報告日: 2020-03-31), 10-K (報告日: 2019-12-31), 10-Q (報告日: 2019-09-30), 10-Q (報告日: 2019-06-30), 10-Q (報告日: 2019-03-31).

2024年第1 四半期に比べて株主資本利益率(ROE)が増加した主な理由は、総資産利益率(ROA)で測定される収益性の向上です。

ROEを3つの要素に分解

Elevance Health Inc.、 ROE の分解(四半期データ)

Microsoft Excel
ROE = 純利益率 × 資産回転率 × 財務レバレッジ比率
2024/03/31 15.38% = 3.66% × 1.52 × 2.76
2023/12/31 15.23% = 3.52% × 1.56 × 2.77
2023/09/30 15.82% = 3.63% × 1.52 × 2.88
2023/06/30 16.78% = 3.89% × 1.51 × 2.86
2023/03/31 16.62% = 3.89% × 1.46 × 2.92
2022/12/31 16.59% = 3.87% × 1.51 × 2.83
2022/09/30 17.26% = 4.09% × 1.48 × 2.86
2022/06/30 17.04% = 4.13% × 1.47 × 2.82
2022/03/31 17.36% = 4.37% × 1.42 × 2.79
2021/12/31 16.93% = 4.46% × 1.41 × 2.70
2021/09/30 15.44% = 4.17% × 1.35 × 2.74
2021/06/30 12.10% = 3.32% × 1.33 × 2.75
2021/03/31 13.92% = 3.82% × 1.29 × 2.83
2020/12/31 13.77% = 3.78% × 1.39 × 2.61
2020/09/30 14.61% = 4.26% × 1.34 × 2.55
2020/06/30 17.17% = 5.27% × 1.28 × 2.55
2020/03/31 15.08% = 4.42% × 1.31 × 2.60
2019/12/31 15.15% = 4.66% × 1.33 × 2.44
2019/09/30 — = — × — × 2.48
2019/06/30 — = — × — × 2.46
2019/03/31 — = — × — × 2.48

レポートに基づく: 10-Q (報告日: 2024-03-31), 10-K (報告日: 2023-12-31), 10-Q (報告日: 2023-09-30), 10-Q (報告日: 2023-06-30), 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31), 10-K (報告日: 2020-12-31), 10-Q (報告日: 2020-09-30), 10-Q (報告日: 2020-06-30), 10-Q (報告日: 2020-03-31), 10-K (報告日: 2019-12-31), 10-Q (報告日: 2019-09-30), 10-Q (報告日: 2019-06-30), 10-Q (報告日: 2019-03-31).

2024年第1 四半期に比べて株主資本利益率(ROE)が増加した主な理由は、純利益率で測定される収益性の向上です。

ROEを5つの要素に分解

Elevance Health Inc.、 ROE の分解(四半期データ)

Microsoft Excel
ROE = 税負担 × 利息負担 × EBITマージン × 資産回転率 × 財務レバレッジ比率
2024/03/31 15.38% = 0.78 × 0.89 × 5.33% × 1.52 × 2.76
2023/12/31 15.23% = 0.78 × 0.88 × 5.14% × 1.56 × 2.77
2023/09/30 15.82% = 0.78 × 0.89 × 5.27% × 1.52 × 2.88
2023/06/30 16.78% = 0.77 × 0.90 × 5.64% × 1.51 × 2.86
2023/03/31 16.62% = 0.77 × 0.90 × 5.60% × 1.46 × 2.92
2022/12/31 16.59% = 0.77 × 0.90 × 5.54% × 1.51 × 2.83
2022/09/30 17.26% = 0.77 × 0.91 × 5.83% × 1.48 × 2.86
2022/06/30 17.04% = 0.77 × 0.91 × 5.89% × 1.47 × 2.82
2022/03/31 17.36% = 0.77 × 0.91 × 6.24% × 1.42 × 2.79
2021/12/31 16.93% = 0.77 × 0.91 × 6.38% × 1.41 × 2.70
2021/09/30 15.44% = 0.77 × 0.90 × 5.98% × 1.35 × 2.74
2021/06/30 12.10% = 0.77 × 0.88 × 4.94% × 1.33 × 2.75
2021/03/31 13.92% = 0.75 × 0.89 × 5.75% × 1.29 × 2.83
2020/12/31 13.77% = 0.73 × 0.89 × 5.81% × 1.39 × 2.61
2020/09/30 14.61% = 0.74 × 0.90 × 6.45% × 1.34 × 2.55
2020/06/30 17.17% = 0.76 × 0.91 × 7.66% × 1.28 × 2.55
2020/03/31 15.08% = 0.78 × 0.89 × 6.36% × 1.31 × 2.60
2019/12/31 15.15% = 0.80 × 0.89 × 6.53% × 1.33 × 2.44
2019/09/30 — = — × — × — × — × 2.48
2019/06/30 — = — × — × — × — × 2.46
2019/03/31 — = — × — × — × — × 2.48

レポートに基づく: 10-Q (報告日: 2024-03-31), 10-K (報告日: 2023-12-31), 10-Q (報告日: 2023-09-30), 10-Q (報告日: 2023-06-30), 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31), 10-K (報告日: 2020-12-31), 10-Q (報告日: 2020-09-30), 10-Q (報告日: 2020-06-30), 10-Q (報告日: 2020-03-31), 10-K (報告日: 2019-12-31), 10-Q (報告日: 2019-09-30), 10-Q (報告日: 2019-06-30), 10-Q (報告日: 2019-03-31).

2024年第1 四半期に株主資本利益率(ROE)が増加した主な理由は、EBITマージン比率で測定した営業利益率の向上です。

ROAを2つのコンポーネントに分解

Elevance Health Inc.、 ROA の分解(四半期データ)

Microsoft Excel
ROA = 純利益率 × 資産回転率
2024/03/31 5.58% = 3.66% × 1.52
2023/12/31 5.50% = 3.52% × 1.56
2023/09/30 5.50% = 3.63% × 1.52
2023/06/30 5.87% = 3.89% × 1.51
2023/03/31 5.69% = 3.89% × 1.46
2022/12/31 5.86% = 3.87% × 1.51
2022/09/30 6.03% = 4.09% × 1.48
2022/06/30 6.05% = 4.13% × 1.47
2022/03/31 6.21% = 4.37% × 1.42
2021/12/31 6.26% = 4.46% × 1.41
2021/09/30 5.63% = 4.17% × 1.35
2021/06/30 4.40% = 3.32% × 1.33
2021/03/31 4.93% = 3.82% × 1.29
2020/12/31 5.28% = 3.78% × 1.39
2020/09/30 5.72% = 4.26% × 1.34
2020/06/30 6.72% = 5.27% × 1.28
2020/03/31 5.80% = 4.42% × 1.31
2019/12/31 6.21% = 4.66% × 1.33
2019/09/30 — = — × —
2019/06/30 — = — × —
2019/03/31 — = — × —

レポートに基づく: 10-Q (報告日: 2024-03-31), 10-K (報告日: 2023-12-31), 10-Q (報告日: 2023-09-30), 10-Q (報告日: 2023-06-30), 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31), 10-K (報告日: 2020-12-31), 10-Q (報告日: 2020-09-30), 10-Q (報告日: 2020-06-30), 10-Q (報告日: 2020-03-31), 10-K (報告日: 2019-12-31), 10-Q (報告日: 2019-09-30), 10-Q (報告日: 2019-06-30), 10-Q (報告日: 2019-03-31).

2024年第1 四半期に比べて総資産利益率(ROA)が増加した主な理由は、純利益率で測定される収益性の向上です。

ROAを4つの要素に分解

Elevance Health Inc.、 ROA の分解(四半期データ)

Microsoft Excel
ROA = 税負担 × 利息負担 × EBITマージン × 資産回転率
2024/03/31 5.58% = 0.78 × 0.89 × 5.33% × 1.52
2023/12/31 5.50% = 0.78 × 0.88 × 5.14% × 1.56
2023/09/30 5.50% = 0.78 × 0.89 × 5.27% × 1.52
2023/06/30 5.87% = 0.77 × 0.90 × 5.64% × 1.51
2023/03/31 5.69% = 0.77 × 0.90 × 5.60% × 1.46
2022/12/31 5.86% = 0.77 × 0.90 × 5.54% × 1.51
2022/09/30 6.03% = 0.77 × 0.91 × 5.83% × 1.48
2022/06/30 6.05% = 0.77 × 0.91 × 5.89% × 1.47
2022/03/31 6.21% = 0.77 × 0.91 × 6.24% × 1.42
2021/12/31 6.26% = 0.77 × 0.91 × 6.38% × 1.41
2021/09/30 5.63% = 0.77 × 0.90 × 5.98% × 1.35
2021/06/30 4.40% = 0.77 × 0.88 × 4.94% × 1.33
2021/03/31 4.93% = 0.75 × 0.89 × 5.75% × 1.29
2020/12/31 5.28% = 0.73 × 0.89 × 5.81% × 1.39
2020/09/30 5.72% = 0.74 × 0.90 × 6.45% × 1.34
2020/06/30 6.72% = 0.76 × 0.91 × 7.66% × 1.28
2020/03/31 5.80% = 0.78 × 0.89 × 6.36% × 1.31
2019/12/31 6.21% = 0.80 × 0.89 × 6.53% × 1.33
2019/09/30 — = — × — × — × —
2019/06/30 — = — × — × — × —
2019/03/31 — = — × — × — × —

レポートに基づく: 10-Q (報告日: 2024-03-31), 10-K (報告日: 2023-12-31), 10-Q (報告日: 2023-09-30), 10-Q (報告日: 2023-06-30), 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31), 10-K (報告日: 2020-12-31), 10-Q (報告日: 2020-09-30), 10-Q (報告日: 2020-06-30), 10-Q (報告日: 2020-03-31), 10-K (報告日: 2019-12-31), 10-Q (報告日: 2019-09-30), 10-Q (報告日: 2019-06-30), 10-Q (報告日: 2019-03-31).

2024年第1 四半期に比べて総資産利益率(ROA)が増加した主な理由は、EBITマージン率で測定した営業収益性の向上です。

純利益率の分解

Elevance Health Inc.、純利益率の分解(四半期データ)

Microsoft Excel
純利益率 = 税負担 × 利息負担 × EBITマージン
2024/03/31 3.66% = 0.78 × 0.89 × 5.33%
2023/12/31 3.52% = 0.78 × 0.88 × 5.14%
2023/09/30 3.63% = 0.78 × 0.89 × 5.27%
2023/06/30 3.89% = 0.77 × 0.90 × 5.64%
2023/03/31 3.89% = 0.77 × 0.90 × 5.60%
2022/12/31 3.87% = 0.77 × 0.90 × 5.54%
2022/09/30 4.09% = 0.77 × 0.91 × 5.83%
2022/06/30 4.13% = 0.77 × 0.91 × 5.89%
2022/03/31 4.37% = 0.77 × 0.91 × 6.24%
2021/12/31 4.46% = 0.77 × 0.91 × 6.38%
2021/09/30 4.17% = 0.77 × 0.90 × 5.98%
2021/06/30 3.32% = 0.77 × 0.88 × 4.94%
2021/03/31 3.82% = 0.75 × 0.89 × 5.75%
2020/12/31 3.78% = 0.73 × 0.89 × 5.81%
2020/09/30 4.26% = 0.74 × 0.90 × 6.45%
2020/06/30 5.27% = 0.76 × 0.91 × 7.66%
2020/03/31 4.42% = 0.78 × 0.89 × 6.36%
2019/12/31 4.66% = 0.80 × 0.89 × 6.53%
2019/09/30 — = — × — × —
2019/06/30 — = — × — × —
2019/03/31 — = — × — × —

レポートに基づく: 10-Q (報告日: 2024-03-31), 10-K (報告日: 2023-12-31), 10-Q (報告日: 2023-09-30), 10-Q (報告日: 2023-06-30), 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31), 10-K (報告日: 2020-12-31), 10-Q (報告日: 2020-09-30), 10-Q (報告日: 2020-06-30), 10-Q (報告日: 2020-03-31), 10-K (報告日: 2019-12-31), 10-Q (報告日: 2019-09-30), 10-Q (報告日: 2019-06-30), 10-Q (報告日: 2019-03-31).

2024年第1 四半期に純利益率が増加した主な理由は、EBIT利益率で測定される営業収益性の増加です。